Cargando…

Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development

The present use of mRNA vaccines against COVID-19 has shown for the first time the potential of mRNA vaccines for infectious diseases. Here we will summarize the current knowledge about improved mRNA vaccines, i.e., the self-amplifying mRNA (saRNA) vaccines. This approach may enhance antigen express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Christin, Schnierle, Barbara S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863218/ https://www.ncbi.nlm.nih.gov/pubmed/36678486 http://dx.doi.org/10.3390/pathogens12010138

Ejemplares similares

An Update on Self-Amplifying mRNA Vaccine Development
por: Blakney, Anna K., et al.
Publicado: (2021)

Chikungunya Vaccine Candidates: Current Landscape and Future Prospects
por: Schmidt, Christin, et al.
Publicado: (2022)

A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune Responses
por: Schmidt, Christin, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency
por: Anderluzzi, Giulia, et al.
Publicado: (2022)

COVID-19 mRNA vaccines: Platforms and current developments
por: Szabó, Gábor Tamás, et al.
Publicado: (2022)

Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines
por: Elliott, Tamara, et al.
Publicado: (2022)

Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ
por: Cu, Yen, et al.
Publicado: (2013)

Self-Amplifying RNA Viruses as RNA Vaccines
por: Lundstrom, Kenneth
Publicado: (2020)

Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
por: Vogel, Annette B., et al.
Publicado: (2018)

Amplifying mRNA vaccines: potential versatile magicians for oncotherapy
por: Hu, Chaoying, et al.
Publicado: (2023)

Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
por: Versteeg, Leroy, et al.
Publicado: (2019)

A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections
por: Schmidt, Christin, et al.
Publicado: (2022)

Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens
por: Snoeck, Janne, et al.
Publicado: (2023)

Self-amplifying RNA vaccines for infectious diseases
por: Bloom, Kristie, et al.
Publicado: (2020)

Self-assembled mRNA vaccines
por: Kim, Jeonghwan, et al.
Publicado: (2021)

Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
por: Chivukula, Sudha, et al.
Publicado: (2021)

Rational development of multicomponent mRNA vaccine candidates against mpox
por: Zhang, Rong-Rong, et al.
Publicado: (2023)

mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
por: Xu, Shuqin, et al.
Publicado: (2020)

Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases
por: Rouf, Nusrat Zahan, et al.
Publicado: (2022)

Rise of the RNA machines – self-amplification in mRNA vaccine design
por: Comes, Jerome D.G., et al.
Publicado: (2023)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models
por: Maruggi, Giulietta, et al.
Publicado: (2022)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
por: Ilyichev, A.A., et al.
Publicado: (2020)

RNA modification in mRNA cancer vaccines
por: Mei, Yingxue, et al.
Publicado: (2023)

Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2014)

Recent Advancement in mRNA Vaccine Development and Applications
por: Al Fayez, Nojoud, et al.
Publicado: (2023)

Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials
por: Whitley, Jill, et al.
Publicado: (2022)

2346. Preliminary results of durable immune response induced by a self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidate, GRT-R910, in adults previously vaccinated with mRNA or AZD1222 primary series
por: Uriel, Alison, et al.
Publicado: (2023)

mRNA vaccines: the most recent clinical applications of synthetic mRNA
por: Kwon, Suji, et al.
Publicado: (2022)

2372. Preliminary evidence of durable immune responses induced by self-amplifying mRNA (samRNA) vaccine candidates against SARS-CoV-2 in vaccine-naive South African population
por: Koen, A, et al.
Publicado: (2023)

Future considerations for the mRNA-lipid nanoparticle vaccine platform
por: Igyártó, Botond Z, et al.
Publicado: (2021)

Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine
por: Ong, Eugenia Z., et al.
Publicado: (2022)

Neo-Antigen mRNA Vaccines
por: Esprit, Arthur, et al.
Publicado: (2020)

COVID-19 mRNA vaccines
por: Huang, Qingrui, et al.
Publicado: (2021)

mRNA Vaccines against Flaviviruses
por: Wollner, Clayton J., et al.
Publicado: (2021)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

The Delivery of mRNA Vaccines for Therapeutics
por: Nitika,, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ps12mt3pvib392fv171abp9ia6